The TAT-pep5 (p75 inhibitor) and the exogenous BDNF can upregulate the ratio, which may be a potential therapeutic treatment of anesthesia/surgery-induced cognitive impairment. The gene discussed is BDNF; the disease is Cognitive impairment.